[OH:1][CH:2]([CH:6]1[S:11][CH2:10][CH2:9][N:8]([C:12]2[CH:17]=[CH:16][C:15]([CH3:18])=[CH:14][CH:13]=2)[C:7]1=[O:19])[C:3]([OH:5])=O.[NH2:20][C:21]1[CH:26]=[CH:25][C:24]([C:27]2[NH:28][O:29][C:30](=[O:32])[N:31]=2)=[CH:23][CH:22]=1.IC1C=C(C=CC=1)C(O)=O.FC1(F)CCNCC1>>[OH:1][CH:2]([CH:6]1[S:11][CH2:10][CH2:9][N:8]([C:12]2[CH:17]=[CH:16][C:15]([CH3:18])=[CH:14][CH:13]=2)[C:7]1=[O:19])[C:3]([NH:20][C:21]1[CH:22]=[CH:23][C:24]([C:27]2[NH:31][C:30](=[O:32])[O:29][N:28]=2)=[CH:25][CH:26]=1)=[O:5]According to the Step 77-1 in synthetic method for EXAMPLE 77, compound 112-2 (0.55 g) and 3-(4-aminophenyl)-1,2,4-oxadiazol-5(2H)-one (0.52 g) were used instead of 3-iodobenzoic acid and 4,4-difluoropiperidine to obtain compound 112-3 (0.52 g) as a pale yellow amorphous solid.
読み込み中…